Marrone Bio Innovations, Inc

120 articles with Marrone Bio Innovations, Inc

• Marrone Bio Innovations Partners with ATP Nutrition to Distribute Stargus® Biofungicide in CanadaAgreement Marks Expansion into the Broad Acre Crops Market

  6/3/2021

  Marrone Bio Innovations, Inc . (NASDAQ: MBII) (MBI or “Marrone Bio”), an international leader in sustainable bioprotection and plant health solutions to support global agricultural needs, has entered into a partnership with ATP Nutrition of Manitoba, Canada to distribute Stargus Biofungicide on Canadian broad acre crops; primarily canola, dry beans, peas, soybeans and sunflower.

• Marrone Bio Innovations, Inc. Reports First-Quarter 2021 Financial Results

  5/13/2021

  Marrone Bio Innovations, Inc. has provided its financial results for the first quarter ended March 31, 2021.

• Marrone Bio Innovations Issues Shareholder Letter - May 13, 2021

  5/13/2021

  Marrone Bio Innovations, Inc., an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, released an update letter to shareholders from Chief Executive Officer Kevin Helash.

• BIOSt® Nematicide Seed Treatment Reduces Greenhouse Gas Emissions in Soybeans and Corn by 85%+ Compared to Conventional PesticidesProduct Receives Outstanding Climate Impact Score in Independent Study

  5/6/2021

  Marrone Bio Innovations, Inc., an international leader in sustainable agricultural biological solutions, announced that BIOSt Nematicide seed treatment product, achieved an outstanding climate impact score of 9.8 out of 10.

• Marrone Bio Innovations to Report First Quarter 2021 Results on Thursday, May 13th at 4:30 p.m. Eastern Time

  4/29/2021

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the first quarter ended March 31, 2021, after market close on Thursday, May 13, 2021 at 4:30 p.m. Eastern time.

• Marrone Bio Innovations Issues Shareholder Letter - Apr 28, 2021

  4/28/2021

  Marrone Bio Innovations, Inc., an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, released an update letter to shareholders from Chief Executive Officer Kevin Helash.

• Marrone Bio Innovations Joins United Nations Global Compact & Launches Environmental, Social & Governance Initiative

  3/29/2021

  Biological Crop Protection Company Leads the Industry with Independent Climate Impact Assessment of Products

• Marrone Bio Innovations Issues Shareholder Letter - Mar 23, 2021

  3/23/2021

  Marrone Bio Innovations, Inc., an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, released a letter to shareholders from Chief Executive Officer, Kevin Helash.

• Marrone Bio Innovations to Report Fourth Quarter and Full Year 2020 Results on Tuesday, March 23rd at 4:30 p.m. Eastern Time

  3/10/2021

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the fourth quarter and full year ended December 31, 2020, after market close on Tuesday, March 23, 2021 at 4:30 p.m. Eastern time.

• Marrone Bio Innovations Issues Shareholder Letter

  2/3/2021

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today released a letter to shareholders from Chief Executive Officer, Kevin Helash.

• Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered

  1/5/2021

  Marrone Bio Innovations, Inc. (NASDAQ: MBII), a leading provider of effective and environmentally responsible pest management and plant health products, today provided an update on its warrant transactions. Effective Dec. 29, 2020, an amendment was made to a prior warrant agreement with Van Herk Investments that extends the maturities of its existing warrants. As a result, Van Herk exercised 33.3% of its outstanding warrants, reducing the tot

• Marrone Bio Innovations Announces Effectiveness of Form S-3 Resale Registration StatementNo Offer of New Securities; Registration Statement Permits Resale of Common Stock from Warrant Financing Exercises

  1/5/2021

  Marrone Bio Innovations, Inc. (Nasdaq:  MBII ) (MBI),  a leading provider of effective and environmentally responsible pest management and plant health products, announced today that its Form S-3 resale registration statement relating to the potential resale of shares of common stock, including common stock issuable upon the exercise of warrants held by certain shareholders per the Company’s previously announced warrant transaction, has been d

• PGG Wrightson Seeds to Distribute Marrone Bio Innovations’ Pro Farm UBP Seed Treatment in Uruguay

  12/21/2020

  Farmers in Uruguay will have a new solution to grow a more sustainable crop thanks to a new arrangement that will allow PGG Wrightson Seeds, New Zealand’s largest seed company, to distribute Marrone Bio Innovations, Inc.’s line of Pro Farm Technology products.

• Marrone Bio Innovations, Inc. Reports Third-Quarter 2020 Financial Results

  11/9/2020

  Expansion in international and seed treatment markets led revenue growth and gross margin improvement

• Marrone Bio Innovations Issues Shareholder Letter and Provides Operational Update

  10/19/2020

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today released a letter to shareholders from Chief Executive Officer, Kevin Helash. Dear Shareholders: As we close the third quarter, I wanted to take the opportunity to provide you with an update on our business and the steps we are taking to

• Marrone Bio Innovations Announces Plans for CFO SuccessionPresident and CFO James Boyd to Retire from the Company; Search Process for New CFO Underway

  9/22/2020

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, announced today that company President and Chief Financial Officer James Boyd will retire from his positions. A national search process for the new Chief Financial Officer is underway, and Mr. Boyd will continue as President and CFO during the

• Marrone Bio Innovations to Present at H.C. Wainwright 22nd Annual Global Investment Conference

  9/10/2020

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio” or the “Company”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today announced that management will present at the H.C. Wainwright 22nd Annual Global Investment Conference taking place virtually September 14 – 16, 2020. Jim Boyd, Chief Financial Officer, is scheduled to host a virtual pre

• Marrone Bio Innovations to Present at LD Micro 500 Virtual Investor Conference

  8/20/2020

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio” or the “Company”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today announced that management will present at the LD 500 virtual investor conference, hosted by LD Micro and taking place virtually September 1 – 4, 2020. Jim Boyd, Chief Financial Officer of Marrone Bio, is scheduled to host

• Marrone Bio Innovations, Inc. Reports Second Quarter and First Half 2020 Financial Results

  8/10/2020

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio” or the “Company”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, has provided its financial results for the second quarter ended June 30, 2020.

• Vive Crop Protection and Marrone Bio Innovations join forces to bring next-generation crop protection solutions to growers

  8/6/2020

  Marrone Bio Innovations, Inc., an international leader in sustainable bioprotection and plant health solutions, and Vive Crop Protection, a leader in Precision Chemistry solutions and owner of the patented Allosperse® technology, announced an agreement that will provide a suite of ground-breaking products for U.S. growers that combine a leading biological with proven conventional chemistry utilizing the unique Allosperse Delivery System.